Pyridostigmine bromide - Adeptio Pharmaceuticals
Alternative Names: ZedeptineLatest Information Update: 21 May 2025
At a glance
- Originator Adeptio Pharmaceuticals
- Class Antirheumatics; Carbamates; Eye disorder therapies; Pyridines; Small molecules; Urologics
- Mechanism of Action Acetylcholinesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Registered Autoimmune disorders
Most Recent Events
- 19 Nov 2018 Zedeptine is still in preregistration phase for Autoimmune disorders in United Kingdom (Adeptio Pharmaceuticals pipeline, November 2018)
- 26 Aug 2015 Preregistration for Autoimmune disorders in United Kingdom (unspecified route)